SB TEMPUS supports more personalised healthcare for each patient by collecting and analysing medical data using AI.
SOFTBANK GROUP
SoftBank Group backed TempusAI's public offering, at $37 per share, will begin trading on Nasdaq Global Select on Friday.
SoftBank Group partners with Alat to revolutionise Saudi Arabia's manufacturing with a US$150M joint venture in cutting-edge robotics.
Popular Posts
